Theialife is a pioneering biopharmaceutical company specializing in the exploration and advancement of groundbreaking medications aimed at Myopia (nearsightedness). The increasing prevalence of Myopia in recent years, particularly among young children, has reached a crisis level globally. Theialife is dedicated to creating innovative treatments that cater to the unmet requirements of Myopia management. Theialife's latest compound is a pioneering, unique, oral treatment for Myopia in children.